Treating Transitional Age Youth with Clozapine-Presentation and Q&A

Video Transcription

Video Summary

The webinar discussed the use of clozapine in treating transitional age youth with serious mental illness. The speaker, Dr. Kurt Cousins, presented evidence for the efficacy of clozapine in treating schizophrenia, suicidality, bipolar disorder, and aggression in this population. The evidence primarily consisted of case reports, cohort studies, and some controlled trials. The use of clozapine in transitional age youth was found to be effective in reducing symptoms and improving outcomes. The speaker emphasized the need for careful monitoring of side effects, such as neutropenia, myocarditis, weight gain, hypersalivation, constipation, and cognitive dulling. He also discussed the importance of conducting regular lab tests and assessing suicidality and aggression. Dr. Cousins shared anecdotes of successful treatment with clozapine in several young patients with different psychiatric conditions. Overall, the webinar provided guidance and insights on the use of clozapine in the treatment of transitional age youth with serious mental illness. Credits for participating in the webinar were available for healthcare professionals until July 1st of that year.

Keywords

clozapine

transitional age youth

serious mental illness

schizophrenia

suicidality

bipolar disorder

aggression

case reports

cohort studies

controlled trials